Lebanon, NH – Dartmouth Health is making significant strides in medical research, tackling challenges from sleep patterns to early cancer detection and newborn care. A wave of recent studies and initiatives demonstrates the organization’s commitment to innovation across a spectrum of health concerns, impacting patients throughout northern New England and beyond. This commitment to research and innovation is driving advancements in diagnostics, treatment, and preventative care, offering new hope for individuals facing complex medical conditions.
Recent investigations at Dartmouth Health and the University of Michigan are challenging conventional wisdom about sleep. A new study suggests that forcing oneself to wake up at 5 a.m. May not be as beneficial as previously thought. Researchers are exploring the complex relationship between circadian rhythms and overall health, potentially leading to more personalized recommendations for sleep schedules. This research builds on a growing understanding of the importance of sleep for physical and mental well-being, and could have implications for shift workers, early risers, and anyone struggling with sleep disturbances.
Early Detection of Amyloidosis: A Collaborative Approach
Dartmouth Hitchcock Medical Center (DHMC) is at the forefront of research into amyloidosis, a progressive and potentially life-threatening multi-system disorder. Cardiologists, orthopaedic surgeons, and pathologists are collaborating on a groundbreaking project to identify early signs of the disease. The team is focusing on a novel hand screening technique, utilizing synovial tissue biopsies performed during carpal tunnel release surgery to detect amyloid deposits. Researchers aim to develop standardized guidelines for this procedure, potentially enabling earlier diagnosis and intervention for patients at risk.
Amyloidosis occurs when abnormal proteins build up in tissues and organs, disrupting their normal function. Early detection is crucial for effective treatment, and this innovative approach could significantly improve outcomes for affected individuals. The multidisciplinary nature of the research highlights the importance of collaboration in tackling complex medical challenges.
Advancing Cancer Care Through Precision Medicine
Dartmouth Health is likewise making significant progress in cancer research and treatment. The Dartmouth Innovations Accelerator for Cancer, launched in 2020, is translating research concepts into tangible benefits for patients. A key component of this effort is precision cancer medicine, utilizing whole exome sequencing to tailor treatments to individual genetic profiles. Sequencing a patient’s entire genetic code allows oncologists to identify specific mutations driving cancer growth, leading to more targeted and effective therapies.
the establishment of a new hub for cancer research at Dartmouth Cancer Center is fostering collaboration and accelerating scientific discovery. The Prouty Pilot program, funded by donations from the annual Prouty event, supports innovative cancer research projects. These initiatives are driving advancements in cancer prevention, diagnosis, and treatment, offering hope to patients and families affected by this devastating disease.
Innovations in Newborn and Maternal Health
Dartmouth Health Children’s is also contributing to vital research in newborn care. A multi-centered clinical trial has identified a more effective way to care for infants experiencing Neonatal Opioid Withdrawal Syndrome (NOWS). The study demonstrated the effectiveness of a new approach to safely manage withdrawal symptoms in newborns exposed to opioids in the womb. This research is particularly important given the ongoing opioid crisis and its impact on vulnerable populations.
Dartmouth Hitchcock has been selected as the sole U.S. Research site for the development of a first-of-its-kind nasal spray vaccine for COVID-19. This initiative underscores the organization’s commitment to addressing emerging public health threats and developing innovative solutions to protect communities.
Looking Ahead
Dartmouth Health’s dedication to research and innovation extends beyond these specific projects. The organization continues to invest in cutting-edge technologies and attract leading researchers, solidifying its position as a regional and national leader in healthcare. Daisy Goodman, DNP, MPH, CARN-AP, APRN, CNM, was recently named the vice chair of Research for Obstetrics and Gynecology (OB/GYN) at Dartmouth-Hitchcock Health, signaling a continued focus on advancing women’s health research. The next steps for many of these projects involve larger-scale clinical trials and the implementation of new protocols into routine clinical practice.
The ongoing commitment to research at Dartmouth Health promises to deliver even more breakthroughs in the years to approach, improving the lives of patients and shaping the future of healthcare. We encourage readers to share their thoughts and experiences with medical research in the comments below.
